Result Summary for 207499/156
| Protocol ID: | 207499/156 |
| Clinical Study ID: | 207499/156 |
| Official Title: | A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of Cilomilast (15mg BID) in Patients with Chronic Obstructive Pulmonary Disease (COPD). |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | cilomilast |
| Trade/Product Name: | ariflo;ariflo |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
